- Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency
- Devonian Health Group Announces the Appointment of New Board Members and Grant of Stock Options
- Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress
- Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023
- Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress
More ▼
Key statistics
On Wednesday, Arcturus Therapeutics Holdings Inc (ARCT:NMQ) closed at 28.48, -15.74% below its 52-week high of 33.80, set on May 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 27.53 |
---|---|
High | 28.80 |
Low | 26.72 |
Bid | 28.52 |
Offer | 29.70 |
Previous close | 26.75 |
Average volume | 293.35k |
---|---|
Shares outstanding | 26.56m |
Free float | 22.82m |
P/E (TTM) | 7.13 |
Market cap | 710.56m USD |
EPS (TTM) | 3.75 USD |
Data delayed at least 15 minutes, as of Jun 07 2023 21:00 BST.
More ▼